Aileron Therapeutics
ALRN
#9832
Rank
A$67.13 M
Marketcap
A$3.10
Share price
9.33%
Change (1 day)
-39.55%
Change (1 year)

Earnings for Aileron Therapeutics (ALRN)

Earnings in 2024 (TTM): -A$44.07 Million

According to Aileron Therapeutics 's latest financial reports the company's current earnings are N/A. In 2023 the company made an earning of -A$22.54 Million, an increase over its 2022 earnings that were of -A$40.6 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Aileron Therapeutics from 2016 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -A$44.07 Million95.52%
2023 -A$22.54 Million-44.49%
2022 -A$40.6 Million3.92%
2021 -A$39.07 Million29.81%
2020 -A$30.1 Million-31.58%
2019 -A$44 Million-6.1%
2018 -A$46.85 Million38.66%
2017 -A$33.79 Million26.63%
2016 -A$26.69 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
ORIC Pharmaceuticals
ORIC
-A$0.22 Billion 399.79%๐Ÿ‡บ๐Ÿ‡ธ USA